Becton Dickinson EBITDA 2010-2025 | BDX

Becton Dickinson EBITDA for the quarter ending March 31, 2025 was $1.155B, a 11.49% decline year-over-year.

  • Becton Dickinson 2024 EBITDA was 4.684B, a 6.48% increase from 2023.
  • Becton Dickinson 2023 EBITDA was 4.399B, a 2.5% decline from 2022.
  • Becton Dickinson 2022 EBITDA was 4.512B, a 0.69% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Becton Dickinson EBITDA 2010-2025 | BDX

  • Becton Dickinson 2024 EBITDA was 4.684B, a 6.48% increase from 2023.
  • Becton Dickinson 2023 EBITDA was 4.399B, a 2.5% decline from 2022.
  • Becton Dickinson 2022 EBITDA was 4.512B, a 0.69% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$87.4B
Cardinal Health (CAH)$32.5B
Straumann Holding AG (SAUHY)$18.7B
Labcorp (LH)$18.2B
Cooper (COO)$15.9B
West Pharmaceutical Services (WST)$14.6B
Align Technology (ALGN)$12.5B
Henry Schein (HSIC)$7.9B
Merit Medical Systems (MMSI)$5.4B
Patterson (PDCO)$2.8B
DENTSPLY SIRONA (XRAY)$2.6B
CONMED (CNMD)$1.5B
STAAR Surgical (STAA)$833M
Pro-Dex (PDEX)$198M
Lifevantage (LFVN)$169M